LONDON, June 23, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 25 companies including many key and niche players such as -
Abbott Laboratories
Alere, Inc.
ARKRAY, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Download the full report: https://www.reportbuyer.com/product/197150/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definition and Scope of Study I-3 HbA1c Laboratory Testing..............I-3 HbA1c Point of Care Testing..............I-3
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW.............. II-1 HbA1c Devices: Critical Role in Monitoring & Management of Diabetes.............. II-1 Growth Stimulants in a Nutshell II-2 Major Concerns.............. II-2 POC-based HbA1c Testing Challenges the Dominance of Laboratory-based HbA1c Testing Market II-2 Increasing Diabetes Prevalence & Need for Diabetes Management to Prop-up Demand for HbA1c Testing Devices II-3 Table 1: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart)..............II-5
Table 2: Global Prevalence (%) of Diabetes in Adults (20-79) by Region (2015 & 2040) (includes corresponding Graph/Chart) II-5
Table 3: Leading Countries by Health Expenditure on Diabetes (2015 & 2040) (in US$ Billion) (includes corresponding Graph/Chart).............. II-6
Table 4: Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2015) (includes corresponding Graph/Chart)..............II-7
Table 5: Health Expenditure on Diabetes by Region: Average Diabetes-related Spending per Person with Diabetes in US$ for 2015 (includes corresponding Graph/Chart) II-8
Table 6: Health Expenditure on Diabetes (2015): Average Diabetes-related Spending per Person with Diabetes (US$) in Select Countries (includes corresponding Graph/Chart) II-9 High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market..............II-10 Table 7: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart).............. II-10
Table 8: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)..............II-11 Increasing Obesity Levels Underpins Market Growth II-12 Table 9: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart)..............II-12
Table 10: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart) II-13 Developing Nations: Growth Opportunities Abound for HbA1c Testing Market.............. II-13 Manufacturers Focus on Offering Products for Developing Markets II-14 Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market.............. II-14 Table 11: Global Per Capita Healthcare Spending (in US$) by Geographic Region for the Year 2014 (includes corresponding Graph/Chart).............. II-15
Table 12: Healthcare Spending as % of GDP by Geographic Region (2016E) (includes corresponding Graph/Chart) II-16
Table 13: Top Countries with the Highest Per Capita Healthcare Spending (2014) (includes corresponding Graph/Chart).............. II-16 Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap.............. II-17 Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?.............. II-17 Technology Developments Transform Diagnostics in Diabetes Care II-17 HbA1c Tests for Diabetes Diagnosis - Need to Address Issues Related to Hemoglobin Variants II-18 Efforts Focus on Standardization Reporting of HbA1c Results II-19 Consistent and Precise Test Results Favor Growth in the HbA1c Testing Devices Market..............II-20 Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis.............. II-20 Near Patient Testing Gaining Ground II-20 Despite Reliability Issues, Prospects Remain Positive for POC Testing Market.............. II-20 Advantages of POC HbA1c Tests over Lab Tests to Foster Adoption II-21 Major Testing Methods in POC HbA1c Tests II-22 Immunoassays.............. II-22 Boronate Affinity Chromatography II-22 Micro-Optical Detection Methods II-23 Select HbA1c POC Tests in the Market - A Comparison II-23 Home HbA1c Testing - Lack of Reimbursement Coverage & Accuracy Concerns Affect Adoption..............II-24 Regular HbA1c Test Keeps Heart Risk at Bay II-25 Glycated Albumin - A Potential Threat to HbA1c? II-25 Higher Levels of Glycosylated Hemoglobin Increases Risk of Death II-26 Non-Invasive Glucose Meters and CBGM Devices Threaten HbA1c Market.............. II-26 ESC and ADA Release Revised Guidelines for HbA1c Testing II-28 Study Finds Dentist Visits to be an Opportunity for HbA1c- based Diabetes Screening & Management II-28 Competitive Landscape..............II-29 Table 14: Leading Players in the Global HbA1c Reagent Market (2015E): Percentage Breakdown of Revenues for Siemens and Others (includes corresponding Graph/Chart) II-29 Select Laboratory-based HbA1c Testing Products/Analyzers II-30 Select Point of Care HbA1c Testing Products/Analyzers II-33
2. DIABETES - A BRIEF PROFILE OF THE DISEASE II-35 What Causes Diabetes?..............II-35 Types of Diabetes.............. II-35 Major Types of Diabetes..............II-36 Likely Complications..............II-36 Nephropathy (Kidney Disease)..............II-36 Diabetic Neuropathy (Nerve Damage) II-36 Retinopathy (Damage to the Eye and Blindness) II-37 Poor Healing of Infections and Wounds II-37 Impotence in Men.............. II-37 Periodontal Disease..............II-37 Cardiovascular Disease..............II-37 Interpreting the A1c Range..............II-37 Blood Glucose Level Guidelines in the US II-38 A Glance at Key Diabetes Statistics II-38 Table 15: World Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart) II-38
Table 16: Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2015 & 2040 (includes corresponding Graph/Chart) II-38
Table 17: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender (2015) (includes corresponding Graph/Chart) II-39
Table 18: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (in Million) (includes corresponding Graph/Chart)..............II-39
Table 19: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart) II-40
Table 20: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region (2015) (includes corresponding Graph/Chart) II-41
Table 21: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (2015) (includes corresponding Graph/Chart)..............II-41 Therapeutic Options for Diabetes II-42 Oral Medications for Type 2 Diabetes II-42 Side Effects of Insulin Therapy II-42 Maintaining A1c Test Result Below 7% II-43 Common Diabetes Management Practices II-43
3. PRODUCT OVERVIEW.............. II-44 Hemoglobin - A Brief..............II-44 Hemoglobin A1c- Description..............II-44 HbA1c Monitoring.............. II-44 What is A1c?.............. II-44 1. HbA1c Laboratory Testing..............II-45 2. HbA1c Point of Care Testing & Self-Monitoring II-45 Hemoglobin A1c (HbA1c) Test..............II-45 Interpreting HbA1c Test Readings II-46 Interpreting HbA1c Test Readings II-46 Result of Hemoglobin A1c Test II-46 Clinical Use of A1c Testing..............II-46 Advantages of A1c Assessment & Interpretation II-47 Risks Associated with HbA1c Testing II-47 Methods of Measurement for Glycohemoglobin II-47 Why Opt for HbA1c Testing?..............II-48 The Diabetes Control & Complications Trial (DCCT) II-48 The Kumamoto and UK Prospective Studies II-48 Glycemia Tests Used in Monitoring Diabetes II-48 Urine Glucose Testing..............II-48 Glycated Protein Testing..............II-49 Table 22: Relation Between A1c Level and Mean Plasma Glucose Levels.............. II-49 HbA1c Test Types.............. II-49 HbA1c Laboratory Testing..............II-50 Analytical Techniques Used for Quantifying HbA1c in Labs II-50 Standardization of HbA1c Results II-50 Table 23: CAP Accuracy Grading for HbA1c Measurements (2007-2013).............. II-51 HbA1c Point of Care Testing & Self-Monitoring II-51 Standardization of Glycated Hemoglobin Testing II-52 NGSP Standardization of HbA1c II-52 IFCC Standardization of HbA1c II-52 HbA1c Reporting.............. II-53 Table 24: A1c (%) and Corresponding eAG Number (in mg/dl or mmol/l).............. II-53
4. PRODUCT INNOVATIONS/INTRODUCTIONS II-54 ARKRAY Unveils New Instruments for HbA1c Measurement II-54 Roche Introduces New Cobas C513 Analyser II-54 ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests II-54 ARKRAY Unveils CinQ HbA1c Range of Reagent Kit II-54 Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer.............. II-54 ARKRAY Releases PocketChem A1c HbA1c Analyzer II-54 Beckman Coulter Introduces Next-Generation Hemoglobin A1c II-55 ARKRAY Unveils ADAMS A1c mini Glycated-Hemoglobin Analyzer II-55 Axis-Shield Introduces HbA1c Turbidimetric Immunoassay II-55 Abbott Introduces New A1c Test for Diabetes Diagnosis II-55 Sanofi Introduces Self-Monitoring Device Offering HbA1c Values II-55 ARKRAY Unveils ADAMS Hybrid AH-8290 Dual HbA1c and Glucose Analyzer.............. II-55 ARKRAY Releases ADAMS A1c HA-8180V and ADAMS A1c HA-8180T Analyzers.............. II-56 Sebia Unveils Capillarys HbA1c Assay II-56
5. RECENT INDUSTRY ACTIVITY..............II-57 Siemens Healthcare Rebrands as Siemens Healthineers II-57 Sinocare to Acquire PTS Diagnostics II-57 Abbott Inks Definitive Agreement to Takeover Alere II-57 Bio-Rad Bags FDA Approval for D-100™ System for A1c Testing II-57 Bio-Rad's VARIANT™ II TURBO HbA1c Kit - 2.0 Receives FDA Approval for Use in Diabetes Diagnosis II-57 Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test.............. II-58 Ortho-Clinical Diagnostics Obtains FDA Approval for VITROS® Chemistry Products HbA1c Reagent Kit II-58 Abbott Gains FDA Approval for ARCHITECT Clinical Chemistry HbA1c Test.............. II-58 PTS Acquires Bayer's A1CNow® Product Family II-58 Radiometer Acquires HemoCue..............II-58 BioHermes Acquires HbA1c Technology from Scripps Laboratories II-58
6. FOCUS ON SELECT PLAYERS..............II-59 Abbott Laboratories (US)..............II-59 Alere, Inc. (US).............. II-59 ARKRAY, Inc. (Japan)..............II-60 Beckman Coulter, Inc. (US)..............II-60 Bio-Rad Laboratories, Inc. (US)..............II-61 Diazyme Laboratories Inc. (US) II-61 EKF Diagnostics Holdings Plc (UK) II-62 HemoCue® AB (Sweden)..............II-62 Infopia Co., Ltd. (South Korea)..............II-63 A.Menarini Diagnostics Ltd. (UK) II-63 PTS Diagnostics (US)..............II-64 Roche Diagnostics (Switzerland)..............II-64 Siemens Healthineers (Germany) II-64 Tosoh Bioscience, Inc. (US)..............II-65 Trinity Biotech plc (Ireland)..............II-65
7. GLOBAL MARKET PERSPECTIVE..............II-66 Table 25: World Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-66
Table 26: World Historic Review for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-67
Table 27: World 14-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-68
Table 28: World Recent Past, Current & Future Analysis for Laboratory-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-69
Table 29: World Historic Review for Laboratory-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-70
Table 30: World 14-Year Perspective for Laboratory-based HbA1c Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-71
Table 31: World Recent Past, Current & Future Analysis for Point-of-Care (POC)-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-72
Table 32: World Historic Review for Point-of-Care (POC)-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-73
Table 33: World 14-Year Perspective for Point-of-Care (POC)-based HbA1c Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............II-74
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Outlook.............. III-1 Table 34: Diabetes Statistics in North America & Caribbean (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart).............. III-2
Table 35: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart)..............III-3 Diabetes Statistics in the US - An Overview III-3 Age Factor.............. III-4 Table 36: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart) III-4
Table 37: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart) III-4 Prevalence by Race/Ethnicity..............III-4 Table 38: US Market for Diabetes (2012): Percentage Breakdown of Prevalence by Race/Ethnicity - Non-Hispanic Blacks and Non-Hispanic Whites (includes corresponding Graph/Chart).............. III-5 Mean HbA1c Scores at National Level III-5 Economic Burden of Diabetes..............III-5 Table 39: Direct Medical Expenditure on Diabetes Management in the US (2012): Percentage Share Breakdown of Costs Incurred by Component (includes corresponding Graph/Chart).............. III-6
Table 40: Indirect Costs of Diabetes in the US (2012): Percentage Share Breakdown by Component (includes corresponding Graph/Chart)..............III-6 HbA1c - Increasingly Moving into Physician's Office III-7 HbA1c Testing for Diabetes Detection Gains Support III-7 ADA 2015 Diabetes Diagnostic Criteria III-8 A Glance at Past Recommendations of ADA for HbA1c Testing in Certain Patients..............III-8 Growing Inclination towards CLIA-Waived Tests III-8 Need for Further Stringency in Requirements Arises III-8 Healthcare Reform Legislation: Impact on Diabetes Diagnostics III-9 US Near Patient HbA1c Testing - A Highly Consolidated Market III-10 Table 41: Leading Players in the US Near Patient HbA1c Testing Market (2015E): Percentage Share Breakdown of Revenues for Alere, Siemens and Others (includes corresponding Graph/Chart)..............III-10 Product Approvals/Launches..............III-11 Strategic Corporate Developments III-11 Key Players.............. III-13 B.Market Analytics..............III-17 Table 42: US Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-17
Table 43: US Historic Review for HbA1c Monitoring by Segment- Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-18
Table 44: US 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-19
2. CANADA.............. III-20 A.Market Analysis.............. III-20 Outlook.............. III-20 Diabetes Statistics in Canada..............III-20 Table 45: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart)..............III-20
Table 46: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart) III-20 B.Market Analytics..............III-21 Table 47: Canadian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-21
Table 48: Canadian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-22
Table 49: Canadian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-23
3. JAPAN.............. III-24 A.Market Analysis.............. III-24 Outlook.............. III-24 Product Approvals/Launches..............III-24 Arkray, Inc. - A Major Player..............III-25 B.Market Analytics..............III-26 Table 50: Japanese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-26
Table 51: Japanese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-27
Table 52: Japanese 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-28
4. EUROPE.............. III-29 A.Market Analysis.............. III-29 Outlook.............. III-29 Diabetes Diagnostics Market in Europe - A Promising Outlook III-29 Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption III-30 A Glance at Key Diabetes Statistics in Europe III-30 Table 53: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart) III-30
Table 54: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart) III-31 B.Market Analytics..............III-32 Table 55: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-32
Table 56: European Historic Review for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-33
Table 57: European 14-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-34
Table 58: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-35
Table 59: European Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-36
Table 60: European 14-Year Perspective for HbA1c Monitoring by Segment -Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-37
4a. FRANCE.............. III-38 A.Market Analysis.............. III-38 Outlook.............. III-38 Strategic Corporate Developments III-38 B.Market Analytics..............III-39 Table 61: French Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-39
Table 62: French Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-40
Table 63: French 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-41
4b. GERMANY.............. III-42 A.Market Analysis.............. III-42 Outlook.............. III-42 Strategic Corporate Development III-42 Siemens Healthineers - A Key Player III-42 B.Market Analytics..............III-43 Table 64: German Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-43
Table 65: German Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-44
Table 66: German 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-45
4c. ITALY.............. III-46 Market Analysis.............. III-46 Table 67: Italian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-46
Table 68: Italian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-47
Table 69: Italian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-48
4d. THE UNITED KINGDOM..............III-49 A.Market Analysis.............. III-49 Outlook.............. III-49 Diabetes Statistics & Management - An Insight III-49 Rising Obesity Cases - Increased Risk of Diabetes III-49 Type 1 Diabetes in Children III-50 Table 70: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart).............. III-50 NHS England Launches Action for Diabetes Plan III-50 Product Launch.............. III-51 Key Players.............. III-51 B.Market Analytics..............III-53 Table 71: UK Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-53
Table 72: UK Historic Review for HbA1c Monitoring by Segment- Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-54
Table 73: UK 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-55
4e. SPAIN.............. III-56 Market Analysis.............. III-56 Table 74: Spanish Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-56
Table 75: Spanish Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-57
Table 76: Spanish 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-58
4f. RUSSIA.............. III-59 Market Analysis.............. III-59 Table 77: Russian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-60
Table 78: Russian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-61
Table 79: Russian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-62
4g. REST OF EUROPE.............. III-63 A.Market Analysis.............. III-63 Outlook.............. III-63 Strategic Corporate Developments III-63 Key Players.............. III-63 B.Market Analytics..............III-65 Table 80: Rest of Europe Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-65
Table 81: Rest of Europe Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-66
Table 82: Rest of Europe 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-67
5. ASIA-PACIFIC.............. III-68 A.Market Analysis.............. III-68 Outlook.............. III-68 Diabetes Statistics - An Overview III-68 Table 83: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart) III-69
Table 84: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart).............. III-70
Table 85: Diabetes and Population Statistics in South East Asia (2015 & 2040)..............III-71
Table 86: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart).............. III-71 B.Market Analytics..............III-72 Table 87: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-72
Table 88: Asia-Pacific Historic Review for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-73
Table 89: Asia-Pacific 14-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-74
Table 90: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-75
Table 91: Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-76
Table 92: Asia-Pacific 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-77
5a. CHINA.............. III-78 A.Market Analysis.............. III-78 Outlook.............. III-78 Rising Diabetes Incidence Spurs Growth in Diabetes Diagnostics Market..............III-78 B.Market Analytics..............III-79 Table 93: Chinese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-79
Table 94: Chinese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-80
Table 95: Chinese 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-81
5b. INDIA.............. III-82 A.Market Analysis.............. III-82 Outlook.............. III-82 HbA1c Testing on Growth Spree..............III-82 Growth Stimulants & Challenges in a Nutshell III-82 Rising Diabetes Cases - Opportunities for HbA1c Monitoring Market.............. III-83 Product Launch.............. III-83 B.Market Analytics..............III-84 Table 96: Indian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-84
Table 97: Indian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-85
Table 98: Indian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-86
5c. REST OF ASIA-PACIFIC..............III-87 A.Market Analysis.............. III-87 Outlook.............. III-87 An Insight into Diabetes Statistics in Australia III-87 Table 99: Diabetes Population in Australia (2015): Percentage Share Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart) III-87 Strategic Corporate Development III-88 Infopia Co., Ltd. (South Korea) - A Major Player III-88 B.Market Analytics..............III-89 Table 100: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-89
Table 101: Rest of Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-90
Table 102: Rest of Asia-Pacific 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-91
6. LATIN AMERICA.............. III-92 A.Market Analysis.............. III-92 Outlook.............. III-92 Diabetes in Latin America - A Glance at Key Statistics III-92 Table 103: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).............. III-92
Table 104: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart).............. III-93 B.Market Analytics..............III-94 Table 105: Latin American Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-94
Table 106: Latin American Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-95
Table 107: Latin American 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-96
7. REST OF WORLD.............. III-97 A.Market Analysis.............. III-97 Outlook.............. III-97 Diabetes Statistics in Africa and the Middle East III-97 Table 108: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart) III-97
Table 109: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart) III-98
Table 110: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).............. III-99
Table 111: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in '000s) for Select Countries (includes corresponding Graph/Chart)..............III-100 B.Market Analytics..............III-101 Table 112: Rest of World Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-101
Table 113: Rest of World Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-102
Table 114: Rest of World 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-103
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 25 (including Divisions/Subsidiaries - 33)
The United States (15) Japan (2) Europe (13) - Germany (3) - The United Kingdom (4) - Italy (1) - Rest of Europe (5) Asia-Pacific (Excluding Japan) (3)
Download the full report: https://www.reportbuyer.com/product/197150/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article